Validation of a newly developed immunoassay for TDP-43 in human plasma

The level of TAR DNA-binding protein 43 (TDP-43) in human blood was reported to have potential for use as a specific fluid biomarker, which represents disease-specific pathologies, for TDP-43 proteinopathies, including amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD),...

詳細記述

書誌詳細

出版年:	Heliyon
主要な著者:	Sayo Matsuura, Harutsugu Tatebe, Makoto Higuchi, Takahiko Tokuda
フォーマット:	論文
言語:	英語
出版事項:	Elsevier 2024-01-01
主題:	TDP-43 Plasma biomarker Immunoassay Validation Amyotrophic lateral sclerosis
オンライン･アクセス:	http://www.sciencedirect.com/science/article/pii/S2405844024007035